Vertex Pharmaceuticals (VRTX) ended the recent trading session at $407.90, demonstrating a -1.05% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily ...

The girl was diagnosed with stage 2 of the disease, a status that meant her own immune system was making at least two types ...

To achieve Oracle Validated Integration, partners such as Vertex demonstrate their integrated offering aligns with Oracle integration best practices and performs as documented.

Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

Dr. Rubin adds that oral minoxidil may offer more consistent absorption and better results for some patients compared to topical minoxidil. “Topical minoxidil tends to have fewer systemic effects and ...

In the latest close session, Vertex Pharmaceuticals (VRTX) was down 1.49% at $414.86. The stock's performance was behind the S&P 500's daily loss of 0.28%. Meanwhile, the Dow lost 0.52%, and the ...